TABLE.
Patient Data
| PART | CTE | Total | |
|---|---|---|---|
| Clinical features | |||
| Sample size, n | 32 | 32 | 64 |
| Average age of death (range) | 74 (55–82) | 70 (25–84) | |
| 25–45 (%) | 0 (0) | 4 (12.5) | 4 (6.5) |
| 46–65 (%) | 7 (21.9) | 7 (21.9) | 14 (22.6) |
| 66–85 (%) | 25 (78.1) | 21 (65.6) | 46 (74.2) |
| Sex, male (%) | 32 (100) | 32 (100) | 64 |
| Cognitively impaired* (%) | 4 (12.5) | 18 (60) | 22 (35.5) |
| Neuropathological features | |||
| CERAD score (%)† | |||
| No neuritic plaques (C0) | 32 (100) | 18 (56.2) | 50 (79.4) |
| Sparse (C1) | 0 (0) | 13 (40.6) | 13 (20.6) |
| Moderate (C2) | 0 (0) | 0 (0) | 0 (0) |
| Frequent (C3) | 0 (0) | 0 (0) | 0 (0) |
| Braak stage (%) | |||
| 0 | 4 (12.5) | NA | — |
| I–II | 19 (59.4) | NA | — |
| III–IV | 9 (28.1) | NA | — |
| V–VI | 0 (0) | NA | — |
| CTE stage (%) | |||
| I–II | NA | 8 (25) | — |
| III–IV | NA | 24 (75) | — |
NA, not applicable.
*
Two CTE cases have unknown cognitive status.
†
One CTE case has unknown CERAD stage.